real tirzepatide Weight Loss Options Found | Weight Loss Medication
Description
This GLP-1 medication helps regulate appetite and support long-term weight management when combined with diet and exercise

It belongs to the class of GLP-1 receptor agonists and aids in controlling blood sugar levels by stimulating insulin release and reducing excessive glucagon production

Shrotriya, in a candid chat with ET NOW, added that Novo Nordisk is not worried about competition even after the semaglutide patent expires in India in January 2026, stating that their focus remains on quality, clinical excellence and ensuring a steady supply

Methods A systematic review was conducted following PRISMA 2020 guidelines (PROSPERO: CRD420261305875)

Read up on all our latest blog posts!

Semaglutide, sold by Novo Nordisk under brands such as Ozempic and Wegovy, goes off patent on March 21 in India
